Patient Guide: A Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Characterized by Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 229 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04538664
Status: ACTIVE_NOT_RECRUITING
Condition: Carcinoma, Non-Small-Cell Lung
Phase: PHASE3

Find a Study Location Near You

This study is available at 229 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Duarte, California
  • Orange, California
  • Santa Monica, California
  • • And 226 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily